Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)

University Health Network, Toronto · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
chronic lymphocytic leukemia (cll), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 846715
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.